Welcome new member, Alexion Pharmaceuticals. Alexion's mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all they do. https://alexion.com/ | The New England Council
0:21
FacebookThe New England Council
Welcome new member, Alexion Pharmaceuticals. Alexion's mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously
The New England Council. . Welcome new member, Alexion Pharmaceuticals. Alexion's mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all they do. https://alexion.com/
7 viewsNov 17, 2023
Alexion Pharmaceuticals Products
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion Pharmaceuticals, Inc. | LinkedIn
linkedin.com
Jan 1, 2009
Typically diagnosed in early childhood, #Neurofibromatosis type 1 (NF1) is a rare, progressive, genetic condition that involves the development of nonmalignant tumours that may affect the brain, spinal cord and nerves. | Alexion Pharmaceuticals
0:09
Typically diagnosed in early childhood, #Neurofibromatosis type 1 (NF1) is a rare, progressive, genetic condition that involves the development of nonmalignant tumours that may affect the brain, spinal cord and nerves. | Alexion Pharmaceuticals
FacebookAlexion Pharmaceuticals
38 views1 month ago
Alexion Pharmaceuticals, Inc. Announces New Data from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis Presented at ICNMD Annual Congress
Alexion Pharmaceuticals, Inc. Announces New Data from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis Presented at ICNMD Annual Congress
marketscreener.com
Jul 7, 2016
Top videos
Will New Drug Give Alexion Pharmaceuticals A Boost?
4:25
Will New Drug Give Alexion Pharmaceuticals A Boost?
investors.com
Jul 18, 2014
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
zonebourse.com
Oct 12, 2022
Despite small patient populations, collectively hundreds of people globally are living with a rare disease. It takes around five years to receive a diagnosis, often involving over seven specialists and several misdiagnoses. #RareDiseaseDay #RareDisease | Alexion Pharmaceuticals
0:06
Despite small patient populations, collectively hundreds of people globally are living with a rare disease. It takes around five years to receive a diagnosis, often involving over seven specialists and several misdiagnoses. #RareDiseaseDay #RareDisease | Alexion Pharmaceuticals
FacebookAlexion Pharmaceuticals
25 views2 weeks ago
Alexion Pharmaceuticals Acquisitions
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceuticals
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceuticals
thestreet.com
Dec 12, 2020
Alexion Pharmaceuticals, Inc. | Sung-Kwon Kim
Alexion Pharmaceuticals, Inc. | Sung-Kwon Kim
linkedin.com
1 viewsJun 28, 2019
Alexion Pharmaceuticals is reportedly planning to move its corporate headquarters from New Haven to Boston. That and more top stories from News 8. | WTNH News 8
1:28
Alexion Pharmaceuticals is reportedly planning to move its corporate headquarters from New Haven to Boston. That and more top stories from News 8. | WTNH News 8
FacebookWTNH News 8
16.5K viewsSep 12, 2017
Will New Drug Give Alexion Pharmaceuticals A Boost?
4:25
Will New Drug Give Alexion Pharmaceuticals A Boost?
Jul 18, 2014
investors.com
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des tr…
Oct 12, 2022
zonebourse.com
Despite small patient populations, collectively hundreds of people globally are living with a rare disease. It takes around five years to receive a diagnosis, often involving over seven specialists and several misdiagnoses. #RareDiseaseDay #RareDisease | Alexion Pharmaceuticals
0:06
Despite small patient populations, collectively hundreds of people gl…
25 views2 weeks ago
FacebookAlexion Pharmaceuticals
Alexion Pharmaceuticals, Inc. Announces New Data from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis Presented at ICNMD Annual Congress
Alexion Pharmaceuticals, Inc. Announces New Data from Phase …
Jul 7, 2016
marketscreener.com
Alexion CEO: We are thrilled with FDA approval
Alexion CEO: We are thrilled with FDA approval
Dec 10, 2015
CNBCMeg Tirrell
Maladies rares: AstraZeneca rachète Alexion pour 39 milliards de dollars
Maladies rares: AstraZeneca rachète Alexion pour 39 milliards de dollars
Dec 12, 2020
zonebourse.com
UK nod paves way for AstraZeneca-Alexion deal to close next week
2:45
UK nod paves way for AstraZeneca-Alexion deal to close next week
Jul 14, 2021
ReutersReuters
1:21
Ultomiris (ravulizumab): Uses, How It Works, and Common Side Effects
1.2K views10 months ago
YouTubeDrugs.com
2:49
AstraZeneca to Buy Alexion in $39 Billion Deal
Dec 14, 2020
Bloomberg.com
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceutic…
Dec 12, 2020
thestreet.com
0:14
This year at SIOP Congress, we’re pleased to be presenting our lates…
Oct 11, 2023
linkedin.com
AstraZeneca to buy Alexion for $39 billion to expand in immunology
Dec 12, 2020
Fox BusinessFox Business
1:41
Alexion Pharmaceuticals moving HQ from New Haven to Boston
Dec 9, 2017
fox61.com
1:02
Alexion shares down amid HHS investigation
Jul 6, 2017
CNBC
5:16
S&P 500 | Alexion Pharmaceuticals: Quick 5-Min Overview
118 viewsDec 31, 2023
YouTubeBruno Invest
Alexion Pharma, Still Recovering From Boardroom Troubles, Appoi…
Mar 27, 2017
thestreet.com
AstraZeneca To Buy Former CT-Based Alexion In $39 Billion Deal
Dec 12, 2020
patch.com
“Absorberá” AstraZeneca a farmacéutica Alexion por casi ¡40 …
Dec 13, 2020
tiempo.com.mx
0:45
AstraZeneca buying Alexion Pharmaceuticals in $39 Billion deal
Dec 12, 2020
fox61.com
#maladiesrares #santé #innovation #patients #rarediseaseweek | Alexi…
1 views1 week ago
linkedin.com
#myastheniagravis | Alexion Pharmaceuticals, Inc.
1 views3 months ago
linkedin.com
Alexion Pharmaceuticals, Inc. | LinkedIn
Jan 1, 2009
linkedin.com
1:01
LEAP: Learn, Evolve, Activate, and deliver for Patients
990 viewsApr 15, 2021
YouTubeAlexion Pharmaceuticals, Inc.
1:28
Alexion Pharmaceuticals is reportedly planning to move its co…
16.5K viewsSep 12, 2017
FacebookWTNH News 8
1:46
How Soliris Became a Blockbuster Orphan Drug: Inside Alexion's Win…
443 viewsOct 18, 2024
YouTubeBest Practices
Alexion to Buy Portola for $18 a Share, or $1.41 Billion
May 5, 2020
thestreet.com
3:14
Alexion CEO & CFO out
Dec 12, 2016
CNBC
1:27
Life At Alexion: Passion For Our Work
1.5K viewsMay 3, 2022
YouTubeAlexion Pharmaceuticals, Inc.
Acuerdo con AstraZeneca impulsa acciones de Alexion
Sep 1, 2020
elceo.com
See more videos
Static thumbnail place holder